Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanishk Luhach

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Nutrition|February 12, 2026
Vitamin D3 co-supplementation with EPA and DHA: A Molecular, Clinical and Regulatory PerspectiveManvi Mittal, Iqbal Ahmad, Tanya Nagpal, et al.
Clinical and Experimental Pharmacology & Physiology|January 22, 2021
Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in ratsKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
Acta Neurobiologiae Experimentalis|April 22, 2022
Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stressKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
The Journal of Pharmacy and Pharmacology|August 30, 2021
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorderKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
European Journal of Pharmacology|October 31, 2020
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASDKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
Autism Research : Official Journal of the International Society for Autism Research|August 20, 2021
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stressKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
Alcohol (Fayetteville, N.Y.)|August 22, 2022
Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorderNiti Sharma, Kanishk Luhach, Lalit K Golani, et al.
Molecular and Cellular Neurosciences|November 16, 2023
Neuron navigators: A novel frontier with physiological and pathological implicationsParth Sandeep, Poonam Sharma, Kanishk Luhach, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Nutrition|February 12, 2026
Vitamin D3 co-supplementation with EPA and DHA: A Molecular, Clinical and Regulatory PerspectiveManvi Mittal, Iqbal Ahmad, Tanya Nagpal, et al.
Clinical and Experimental Pharmacology & Physiology|January 22, 2021
Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in ratsKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
Acta Neurobiologiae Experimentalis|April 22, 2022
Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stressKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
The Journal of Pharmacy and Pharmacology|August 30, 2021
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorderKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
European Journal of Pharmacology|October 31, 2020
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASDKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
Autism Research : Official Journal of the International Society for Autism Research|August 20, 2021
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stressKanishk Luhach, Giriraj T Kulkarni, Vijay P Singh, et al.
Alcohol (Fayetteville, N.Y.)|August 22, 2022
Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorderNiti Sharma, Kanishk Luhach, Lalit K Golani, et al.
Molecular and Cellular Neurosciences|November 16, 2023
Neuron navigators: A novel frontier with physiological and pathological implicationsParth Sandeep, Poonam Sharma, Kanishk Luhach, et al.
Pageof 1